RAPT Therapeutics (RAPT) Other financing activities (2020 - 2024)
Historic Other financing activities for Therapeutics (RAPT) over the last 5 years, with Q4 2024 value amounting to $4.6 million.
- Therapeutics' Other financing activities rose 361.26% to $4.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $19.9 million, marking a year-over-year increase of 1664.03%. This contributed to the annual value of $19.9 million for FY2024, which is 1664.03% up from last year.
- According to the latest figures from Q4 2024, Therapeutics' Other financing activities is $4.6 million, which was up 361.26% from $4.6 million recorded in Q3 2024.
- Therapeutics' Other financing activities' 5-year high stood at $5.4 million during Q1 2024, with a 5-year trough of $2.0 million in Q3 2020.
- In the last 5 years, Therapeutics' Other financing activities had a median value of $2.9 million in 2021 and averaged $3.3 million.
- Per our database at Business Quant, Therapeutics' Other financing activities tumbled by 1845.19% in 2021 and then surged by 5864.52% in 2023.
- Over the past 5 years, Therapeutics' Other financing activities (Quarter) stood at $2.6 million in 2020, then fell by 18.45% to $2.1 million in 2021, then soared by 45.01% to $3.0 million in 2022, then surged by 46.41% to $4.4 million in 2023, then grew by 3.61% to $4.6 million in 2024.
- Its last three reported values are $4.6 million in Q4 2024, $4.6 million for Q3 2024, and $5.4 million during Q2 2024.